Skip to content
AwardedUnited KingdomGoods£225,408,000

Live Attenuated Influenza vaccine 2026/2027

Published
Published 19 June 2026
Deadline
Closed 1 July 2026

Overview

The UK Health Security Agency has awarded a contract to AstraZeneca UK Limited for the supply of Live Attenuated Influenza vaccine for 2026/2027. The contract, valued at £225.4 million, was awarded on 31 May 2026.

Key details

Country
United Kingdom
Status
Awarded
Category
Goods
Estimated value
£225,408,000
Procedure
Limited
SME suitable
No
Published
19 June 2026
Deadline
Closed
Classification (CPV)
Influenza vaccines

Award outcome

Awarded value
£225,408,000
Award date
31 May 2026
Contract period
31 July 2026 → 31 July 2028
Winner
  • ASTRAZENECA UK LIMITED

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    19 June 2026

Contracting authority

  • UK Health Security Agency

    Buyer

    London, United Kingdom

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Live Attenuated Influenza vaccine 2026/2027 — won by ASTRAZENECA UK LIMITED — Skim